Healthcare -
Biotechnology - NASDAQ - US
$ 20.285
-1.96 %
$ 15 B
Market Cap
-65.44
P/E
SMMT - CASH FROM OPERATIONS
Cash from Operations SMMT - Summit Therapeutics Inc.
-76.8 M
LAST VALUE
-2.83%
2 YEAR CAGR
-16.91%
5 YEAR CAGR
-23.00%
10 YEAR CAGR